We are excited to collaborate and provide two virtual webinars in September focusing on real-world data! These opportunities are complimentary and are a fantastic way to stay at the forefront of real-world topics. Inclusivity as a Part of Feasibility: Making Trials More Representative with RWD In Collaboration with: Optum September 12 | 12:00-1:00PM ET | Register Here: https://lnkd.in/eZ-BEhZW Raising the Bar on Real-World Data Quality: Ensuring Regulatory-Grade EHR Data In Collaboration with: Truveta September 18 | 1:00-1:45PM ET | Register Here: https://lnkd.in/ejcJks6Y Want more real-world collaboration? Check out our upcoming Real-World Evidence conference in Philadelphia, PA this fall! ➡️ https://lnkd.in/egNfP_gD #RealWorldEvidence #RealWorldData #RWE #RWD #Learning #Webinar
DIA
Pharmaceutical Manufacturing
Washington, DC 37,383 followers
Driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world
Über uns
DIA is the leading global life science membership association driving collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries.
- Website
-
http://www.DIAglobal.org
External link for DIA
- Industrie
- Pharmaceutical Manufacturing
- Größe des Unternehmens
- 51-200 Mitarbeiter
- Hauptsitz
- Washington, DC
- Typ
- Nonprofit
- Gegründet
- 1964
- Spezialitäten
- Professional Association, Pharmaceuticals, Medical Devices, Biotechnology, Education Provider, Government, Clinical Trials, Education, Training, eLearning, Translational Medicine, Patient Engagement, Value and Access, healthcare, regulatory affairs, Pharmaco Vigilance, personaldevelopment, careers, women in science, and medicine
Standorte
Employees at DIA
-
Eli Weinberg, PhD
Developing and delivering innovations in medicine
-
Joe Dustin
VP, Product Strategy | BioFourmis | eClinical Tech Executive | Advisor | AI | eCOA | DHTs | Decentralized Trials | Clinical Operations
-
Timothy Hess
Global Head of Business & Digital Technology at DIA
-
Nimita Limaye
Research VP, Life Sciences R&D Strategy and Technology, at IDC
Aktualisierungen
-
This is your last chance to register for the Pharmacovigilance Quality Management System (PQMS) live-virtual training course! Get acquainted with the principles, approaches, and regulatory expectations for the PQMS in this highly interactive and hands-on course. Plus, watch the video featuring one of the instructors, Jose Alberto Ayala Ortiz from PVpharm, as he highlights the key benefits of this training and why you shouldn't miss out! 🎥 Don’t miss out on this opportunity to deepen your expertise, boost your career, and ensure regulatory compliance in this critical area. Seats are filling fast! Secure yours now: https://bit.ly/3KZ8NiC. #PQMS #DrugSafety #Pharmacovigilance #Learning #QualityManagement
-
Explore the emerging EU AI regulatory landscape and its impact on medicines development with this on-demand session from DIA Europe 2024. The session features a distinguished panel of speakers from the European Commission, industry, regulatory agencies, and patient organisations. Gain key insights into the EMA/HMA's draft reflection paper on AI in medicines, understand the importance of responsible and reliable AI development throughout the medicines lifecycle, and receive practical recommendations from regulators, legislators, patients, and industry. Watch it now: https://bit.ly/474Gvxx. To continue these critical discussions, join us at DIA Europe 2025 in Basel, Switzerland, from 18-20 March, where the focus will be on sustainability, innovation, and collaboration in healthcare. Register now to take advantage of early bird rates available until 14 November: https://bit.ly/3LmbH19. #ArtificialIntelligence #AI #RegulatoryAffairs #DIAEurope #Learning
-
-
DIA reposted this
Physician scientist in translational medicine and early clinical development with experience in tech, biotech pharma, academia and clinical medicine. Specialising in oligonucleotide therapeutics at GSK.
Only 1 day left to secure early bird registration for the DIA/ FDA Oligonucleotide-based Therapeutics Conference (28-30 Oct 2024, Washington DC). It's going to be a great meeting! https://lnkd.in/ed9Ezu3h
-
Join us online for the Medical Writing of PSUR/PRER Training Course, starting on 15 October. Learn more about best practices in source data collection, essential role of quality checks (QC) during the whole process of report preparation, and critical aspects of medical writing, including data editing and presentation. This live-virtual training course will be hosted by: ◾ Sven Schrip, Head of Global Pharmacovigilance Writing, Boehringer Ingelheim, Germany ◾ Jan Kolouch, CEO, Strategic PV Advisor, NextPV Services s.r.o., Czech Republic Don’t miss this unique opportunity to get a firm knowledge foundation on the medical writing of PSUR/PBRER with hands-on exercises. The early bird rate is ending next week. Register today: https://bit.ly/3yMKPEZ. #Pharmacovigilance #DrugSafety #PSUR #MedicalWriting #Learning
-
-
We are counting down the weeks until this year's Real-World Evidence Conference! Our Program Committee has been hard at work to bring you informative, relevant sessions that will allow you translate insights into real-world value. Early Bird rates are available until end of day tomorrow and spots are limited - take advantage and secure your spot today! #RWE24 #RealWorldEvidence #RWE #LifeScience
This content isn’t available here
Access this content and more in the LinkedIn app
-
The preliminary programme for the 2024 DIA Middle East & North Africa (MENA) Conference is now available! Join us in Cairo, Egypt, on 26-27 November for an unparalleled opportunity to engage with key stakeholders in the pharmaceutical sector. This year’s conference will bring together health authorities, industry leaders, academics, and patient representatives to explore the unique opportunities and challenges in the MENA region. Topics include: ◾ Regional regulatory and reliance developments ◾ Digital transformation, AI and RWE ◾ Rare diseases ◾ Advanced therapies ◾ eLabelling ◾ Supply chain and sample management ◾ And much more! Don’t miss out on this great chance to collaborate, connect, and learn from over 300 participants representing countries across the region. Access the full programme here: https://bit.ly/3yQlcD1. #DIAMENA2024 #PharmaInnovation #HealthcareLeadership #MENARegion #RegulatoryScience
-
-
The 2024 DIA India Annual Meeting is right around the corner! This year, we are thrilled to host a lineup of leading experts who will dive into the latest in medical devices, pharmacovigilance, regulatory sciences, and clinical topics. Expect engaging sessions on AI, regulatory challenges, and innovative strategies that will shape the future of healthcare. Connect with top professionals, share insights, and explore new opportunities. Check out our website for the full list of speakers and secure your spot today: https://bit.ly/4bR5YM0. Vinod Mattoo Pravin Nath Dr.Rajesh Kumawat Susan Korah Amrit Gill, MD MBA Anupam Chhabra, MD, MBA Dr Ritu Singal M.D Dr Ashok Swain Nishank Nivedit #DIAIndia #Pharmacovigilance #Clinical #RegulatoryAffairs #MedicalDevices
-
-
FREE WEBINAR: EU Combination Products - Opportunities and Challenges Bringing combination products to the European market is a complex endeavor, often hindered by regulatory challenges. These obstacles can stifle innovation, creating significant barriers to market entry. In this session from DIA Europe 2024, experts from the Medical Products Agency, EMA and industry share their insights on the current regulatory hurdles and discuss potential pathways to foster innovation in the European market. Interested in this topic? Watch the full session on-demand and join us at DIA Europe 2025 to continue these critical discussions. ◾ Access the webinar: https://bit.ly/3Xeh60Q. ◾ Learn more about DIA Europe 2025: https://bit.ly/3xbhliT. #DIAEurope #Learning #CombinationProducts #LifeSciences
-